Compounding Altered- Release Pharmaceuticalsf...Slide 2 Compounding Altered-Release Pharmaceuticals-Part IV Parenteral Miscellaneous Drug Examples that are Good Candidates Excipients

Slide 1

Compounding AlteredCompounding Altered--Release PharmaceuticalsRelease Pharmaceuticals

Part IVPart IV

Loyd V. Allen, Jr., Ph.D.Loyd V. Allen, Jr., Ph.D.

Slide 2

Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals--Part IVPart IV

ParenteralParenteralMiscellaneousMiscellaneousDrug Examples that are Good CandidatesDrug Examples that are Good CandidatesExcipientsExcipients Used For AlteredUsed For Altered--Release Release PharmaceuticalsPharmaceuticalsSummary/ConclusionsSummary/Conclusions

Slide 3

Compounding AlteredCompounding Altered--ReleaseReleasePharmaceuticalsPharmaceuticals--Part IVPart IV

ParenteralParenteral–– InternalInternal–– ExternalExternal–– IV DripIV Drip–– IM InjectionIM Injection

Slide 4

Compounding Compounding ParenteralsParenterals

Slide 5

InternalInternal

Factors AffectingFactors Affecting–– Particle sizeParticle size–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility

Slide 6

InternalInternal

Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/MatricesMaterials/MatricesPreparation MethodsPreparation Methods

Slide 7

HydromorphoneHydromorphone 2% and 2% and BupivacaineBupivacaine HClHCl 0.75% 0.75% IntrathecalIntrathecal Injection, PFInjection, PF

HydromorphoneHydromorphone HClHCl USPUSP 2 g2 gBupivacaineBupivacaine HClHCl UspUsp 750 mg750 mg0.9% Sodium chloride 0.9% Sodium chloride injinj 42 mL42 mLSterile water for injection qsSterile water for injection qs 100 mL100 mL

Slide 8

Morphine sulfate 20 mg/mL and Morphine sulfate 20 mg/mL and ClonidineClonidine HClHCl 10 10 ug/mLug/mL

Epidural InjectionEpidural Injection

Morphine sulfateMorphine sulfate 2 g 2 g ClonidineClonidine HClHCl 1 mg1 mg0.9% Sodium chloride injection 0.9% Sodium chloride injection 69 mL69 mLSterile water for injectionSterile water for injection qsqs 100 mL100 mL

Slide 9

IV Drip/InfusionIV Drip/Infusion

Factors AffectingFactors Affecting–– ConcentrationConcentration–– Diffusion coefficientsDiffusion coefficients–– Partition coefficientsPartition coefficients–– SolubilitySolubility

Slide 10

IV Drip/InfusionIV Drip/Infusion


Slide 11

IM InjectionIM Injection


Slide 12

IM InjectionIM Injection


Slide 13

Progesterone 100 mg/mL in Oil Progesterone 100 mg/mL in Oil InjectionInjection

ProgesteroneProgesterone 10 g10 gBenzyl benzoateBenzyl benzoate 10 mL10 mLBenzyl alcoholBenzyl alcohol 10 mL10 mLSesame oilSesame oil qsqs 100 mL100 mL

Slide 14

ExternalExternal


Slide 15

ExternalExternal


Slide 16

Ambulatory PumpsAmbulatory Pumps

Slide 17

CeftazidimeCeftazidime 20 mg/mL for 20 mg/mL for Ambulatory Infusion PumpAmbulatory Infusion Pump

CeftazidimeCeftazidime 2.5 g2.5 gSterile water for injectionSterile water for injection qsqs0.9% Sodium chloride 0.9% Sodium chloride injinj qsqs 125 mL125 mL

Slide 18

Compounding AlteredCompounding Altered--Release Release PharmaceuticalsPharmaceuticals

MiscellaneousMiscellaneous–– Soaking a membrane or gelatin in solution Soaking a membrane or gelatin in solution

(casting)(casting)–– CyclodextrinsCyclodextrins–– ImplantsImplants–– NanoparticlesNanoparticles–– Resealed ErythrocytesResealed Erythrocytes–– Antibiotic Bone CementAntibiotic Bone Cement–– Antibiotic Beads ImplantedAntibiotic Beads Implanted–– SelfSelf--Regulated Chelating AgentsRegulated Chelating Agents

Slide 19

Soaking A Membrane or Gelatin Soaking A Membrane or Gelatin in Solution (Casting)in Solution (Casting)


Slide 20

Soaking A Membrane or Gelatin Soaking A Membrane or Gelatin in Solution (Casting)in Solution (Casting)


Topical ApplicationTopical Application

Slide 21

CyclodextrinsCyclodextrins


Slide 22

CyclodextrinsCyclodextrins


Slide 23

Slide 24

Slide 25

ImplantsImplants


Slide 26

ImplantsImplants

Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/Matrices (Mg Stearate, PLA, PGA, Materials/Matrices (Mg Stearate, PLA, PGA, Silicone Polymers)Silicone Polymers)Preparation MethodsPreparation Methods

Slide 27

Fibrin GlueFibrin Glue

AprotininAprotinin 70,000 KIU70,000 KIUThrombinThrombin 10,000 IU10,000 IUCalcium chloride 0.5 M solCalcium chloride 0.5 M sol 2 mL2 mL

Slide 28

NanoparticlesNanoparticles


Slide 29

NanoparticlesNanoparticles


Slide 30

Resealed ErythrocytesResealed Erythrocytes


Slide 31



Slide 32


Whole BloodWhole BloodSpin it down and remove the red blood cellsSpin it down and remove the red blood cellsPlace in sterile hypotonic saline or waterPlace in sterile hypotonic saline or waterAdd concentrated sterile solution of drugAdd concentrated sterile solution of drugReadjust tonicity to isotonicReadjust tonicity to isotonicErythrocytes will Erythrocytes will ““resealreseal””Administer to patientAdminister to patient………….last up to 3 weeks.last up to 3 weeks

Slide 33

Antibiotic Bone CementAntibiotic Bone Cement


Mechanism of ReleaseMechanism of ReleaseStabilityStabilityEquipment RequiredEquipment RequiredMaterials/Matrices (Materials/Matrices (PalacosPalacos Bone Cement + Drug)Bone Cement + Drug)Preparation MethodsPreparation Methods

Slide 34

TobramycinTobramycin--Impregnated Impregnated PolymethylmethacrylatePolymethylmethacrylate BeadsBeads

TobramycinTobramycin sulfatesulfate 1.2 g1.2 gPalacosPalacos Bone CementBone Cement 40 g40 g

0.25 inch beads contain approx 3.26 mg of 0.25 inch beads contain approx 3.26 mg of tobramycintobramycin (as the sulfate)(as the sulfate)

Slide 35

VancomycinVancomycin 5 mg Sponge Disks5 mg Sponge Disks

VancomycinVancomycin HClHCl 5 mg5 mgSponge (collagen or gelatin)Sponge (collagen or gelatin) qsqs

Slide 36


Drug Examples That Are Good CandidatesDrug Examples That Are Good CandidatesThe lower the dose the betterThe lower the dose the betterLower solubility is betterLower solubility is betterShort halfShort half--life life vsvs long halflong half--lifelifeLarge therapeutic indexLarge therapeutic index

Slide 37

Drug Examples That Are Good Drug Examples That Are Good CandidatesCandidates

SolubilitySolubilityDoseDoseADMEADME----Duration of actionDuration of actionPharmacokineticsPharmacokinetics

Slide 38


Summary/ConclusionsSummary/ConclusionsYES, some are feasibleYES, some are feasibleNo, some are notNo, some are notQuality Control is importantQuality Control is importantAlways monitor clinical responseAlways monitor clinical response

Slide 39

A LOOK INTO THEA LOOK INTO THENEAR FUTURENEAR FUTURE

New Compounded Drug Delivery Systems New Compounded Drug Delivery Systems (DDS)(DDS)Next 5Next 5--10 years10 years

Slide 40

Future TrendsFuture Trends

Adhesive SiteAdhesive Site--Specific DDSSpecific DDSAntibodyAntibody--Based DDSBased DDSBiocompatible Biocompatible MicrosphereMicrosphere DDSDDSBiodegradable Polymers DDSBiodegradable Polymers DDSBiologicBiologic--Based DDSBased DDSElectromagnetic/RadiationElectromagnetic/Radiation--Activated DDSActivated DDS

Slide 41


ImmunomodulatorImmunomodulator DDSDDSImplantImplant--Enhanced DDSEnhanced DDSMicroorganismMicroorganism--Containing MicrocapsulesContaining MicrocapsulesLipid Lipid MicrocylindersMicrocylindersLiposome EnhancementsLiposome EnhancementsLivingLiving--Cell TherapiesCell Therapies

Slide 42


Magnetic System DDSMagnetic System DDSMazeMaze--Escape DDSEscape DDSMonoclonal Antibody DDSMonoclonal Antibody DDSNovel Nasal DDSNovel Nasal DDSNew Osmotic DDSNew Osmotic DDSTransmucosalTransmucosal DDSDDSPolymer Drug Complex DDSPolymer Drug Complex DDS

Slide 43


PulsatilePulsatile DDSDDSRespiratory DDSRespiratory DDSSelfSelf--Assembling Controlled Release DDSAssembling Controlled Release DDSProgrammed Skin Surface DDSProgrammed Skin Surface DDS

Slide 44

Documents

Compounding Altered- Release Pharmaceuticalsf...Slide 2 Compounding Altered-Release Pharmaceuticals-Part IV Parenteral Miscellaneous Drug Examples that are Good Candidates Excipients